DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes
Djansel Bukovec, Blagojche Gjorgjioski, Monika Simjanoska Misheva, Goran Kungulovski. DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes. // Epigenetics & Chromatin. – 2026. – DOI: 10.1186/s13072-026-00704-y. – URL: https://doi.org/10.1186/s13072-026-00704-y
Djansel Bukovec, Blagojche Gjorgjioski, Monika Simjanoska Misheva, & Goran Kungulovski (2026). DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes. Epigenetics & Chromatin. https://doi.org/10.1186/s13072-026-00704-y
Djansel Bukovec, et al. “DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes.” Epigenetics & Chromatin, 2026. doi:10.1186/s13072-026-00704-y.
@article{Bukovec2026,
title = {DNA methylation variability defines a fundamental dimension of tumor epigenomes linked to genomic instability, tumor aggressiveness, and clinical outcomes},
author = {Bukovec, Djansel and Gjorgjioski, Blagojche and Misheva, Monika Simjanoska and Kungulovski, Goran},
journal = {Epigenetics \& Chromatin},
year = {2026},
doi = {10.1186/s13072-026-00704-y},
url = {https://doi.org/10.1186/s13072-026-00704-y}
}